Davide Soldato
@dsoldatomd
M.D. | Medical Oncologist | PhD Student at @GustaveRoussy & @UnivParisSaclay | Breast Cancer | Clinical Research | Survivorship
ID: 1434129267672092672
https://www.linkedin.com/in/davide-soldato-5194a913a/ 04-09-2021 12:20:50
151 Tweet
1,1K Takipçi
852 Takip Edilen
Amazing conclusion of the first Presidential by Benjamin Besse discussing PAPILLON and LIBRETTO-431. Positive trials but huge amount of resources needed. Risk of preventing pts access to active drugs. Let’s find solutions to stop the *unnecessary*. ESMO - Eur. Oncology OncoAlert #ESMO23